Cameron Reid
About Cameron Reid
Cameron Reid is a Principal Scientist at Bristol Myers Squibb and Vice President of the Board of Directors at OCEAN BEACH COMMUNITY FOUNDATION INC in San Diego, California.
Current Role at Bristol Myers Squibb
Cameron Reid is currently serving as a Principal Scientist at Bristol Myers Squibb in San Diego, California. He began this role in April 2022. In this capacity, Reid leverages his expertise in Pharmaceutical Candidate Optimization (PCO) within the field of Discovery Pharmaceutics to advance the company's drug discovery and development efforts.
Vice President Board of Directors at Ocean Beach Community Foundation Inc
In addition to his scientific career, Cameron Reid holds the position of Vice President on the Board of Directors at the Ocean Beach Community Foundation Inc in San Diego, California. This role highlights his commitment to community service and his ability to balance professional responsibilities with philanthropic endeavors.
Professional Progression at Bristol Myers Squibb
Cameron Reid has held multiple roles at Bristol Myers Squibb, showcasing a remarkable career progression. He started as Scientist I in 2019, progressed to Scientist II in 2020, and then to Senior Scientist from 2020 to 2022 before assuming his current position as Principal Scientist. This rapid progression is a testament to his expertise and contributions to the field.
Diverse Career Background
Cameron Reid's career spans both the public sector and leading private pharmaceutical companies. He has worked at USDA-ARS as a Research Lab Technician, Gilead Sciences in various research roles, and PolyPeptide Group as both a GMP Purification Chemist and Senior Development Chemist. His diverse background in chemistry and formulation science underpins his current work in pharmaceutical research.
Education in Chemistry and Forensic Science
Cameron Reid has a solid educational background with a Bachelor of Applied Science in Chemistry and Forensic Science from Queensland University of Technology (QUT), completed between 2008 and 2010. Additionally, he earned a Cybersecurity Certificate from Champlain College, where he studied Computer Forensics & Digital Investigations from 2013 to 2014. This interdisciplinary education supports his scientific and investigative work in the pharmaceutical field.